What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Surgery
His primary areas of study are Radiation therapy, Surgery, Head and neck cancer, Internal medicine and Cancer.
His work deals with themes such as Survival rate, Epidermoid carcinoma and Retrospective cohort study, which intersect with Radiation therapy.
David I. Rosenthal has included themes like Stroke, Carcinoma and Risk factor in his Surgery study.
His Head and neck cancer study combines topics from a wide range of disciplines, such as Mucositis, Clinical trial, Swallowing, Nuclear medicine and Dysphagia.
His Internal medicine research includes elements of Gastroenterology and Oncology.
His Cancer research integrates issues from Chemotherapy and Nose neoplasm.
His most cited work include:
- Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer (4031 citations)
- Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. (539 citations)
- Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522 (463 citations)
What are the main themes of his work throughout his whole career to date?
David I. Rosenthal mainly focuses on Radiation therapy, Internal medicine, Head and neck cancer, Oncology and Cancer.
As a part of the same scientific family, David I. Rosenthal mostly works in the field of Radiation therapy, focusing on Nuclear medicine and, on occasion, Planning target volume.
His work on Chemoradiotherapy, Hazard ratio, Mucositis and Head and neck squamous-cell carcinoma is typically connected to In patient as part of general Internal medicine study, connecting several disciplines of science.
His Oncology research incorporates elements of Cetuximab and Cisplatin.
The Cancer study combines topics in areas such as Stage, Larynx, Disease and Cohort.
His Surgery research includes themes of Carcinoma and Neck dissection.
He most often published in these fields:
- Radiation therapy (48.38%)
- Internal medicine (34.00%)
- Head and neck cancer (32.15%)
What were the highlights of his more recent work (between 2018-2021)?
- Radiation therapy (48.38%)
- Internal medicine (34.00%)
- Head and neck cancer (32.15%)
In recent papers he was focusing on the following fields of study:
His main research concerns Radiation therapy, Internal medicine, Head and neck cancer, Radiology and Cancer.
His research investigates the connection between Radiation therapy and topics such as Randomized controlled trial that intersect with issues in Adverse effect.
Many of his studies on Internal medicine apply to Oncology as well.
His biological study spans a wide range of topics, including Clinical trial, Nuclear medicine, Asymptomatic, Proportional hazards model and Effective diffusion coefficient.
The study incorporates disciplines such as Larynx, Toxicity and Head and neck in addition to Radiology.
His study in the field of Primary tumor also crosses realms of Microbiome.
Between 2018 and 2021, his most popular works were:
- Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in BRAFV600E-Mutated Anaplastic Thyroid Carcinoma. (37 citations)
- Intensity modulated proton therapy (IMPT) – The future of IMRT for head and neck cancer (26 citations)
- Head and neck surgical oncology in the time of a pandemic: Subsite-specific triage guidelines during the COVID-19 pandemic. (23 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Surgery
David I. Rosenthal spends much of his time researching Radiation therapy, Head and neck cancer, Radiology, Internal medicine and Cancer.
His study in the field of Ablative case is also linked to topics like SABR volatility model.
The concepts of his Head and neck cancer study are interwoven with issues in Odds ratio, Clinical trial and Otorhinolaryngology.
His Internal medicine research is multidisciplinary, relying on both Oncology and Former Smoker.
His research integrates issues of Stage, Swallowing, Dysphagia and Risk factor in his study of Cancer.
His work investigates the relationship between Stent and topics such as Tongue that intersect with problems in Surgery.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
